Amalgamated Bank’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $619K | Buy |
|
|||||
|
2025
Q1 | $564K | Sell |
|
|||||
|
2024
Q4 | $592K | Buy |
|
|||||
|
2024
Q3 | $535K | Buy |
|
|||||
|
2024
Q2 | $435K | Sell |
|
|||||
|
2024
Q1 | $388K | Sell |
|
|||||
|
2023
Q4 | $450K | Sell |
|
|||||
|
2023
Q3 | $386K | Sell |
|
|||||
|
2023
Q2 | $482K | Buy |
|
|||||
|
2023
Q1 | $491K | Sell |
|
|||||
|
2022
Q4 | $481K | Sell |
|
|||||
|
2022
Q3 | $620K | Sell |
|
|||||
|
2022
Q2 | $662K | Buy |
|
|||||
|
2022
Q1 | $829K | Sell |
|
|||||
|
2021
Q4 | $1.2M | Sell |
|
|||||
|
2021
Q3 | $1.1M | Sell |
|
|||||
|
2021
Q2 | $1.59M | Buy |
|
|||||
|
2021
Q1 | $334K | Sell |
|
|||||
|
2020
Q4 | $238K | Buy |
|
|||||
|
2020
Q3 | $226K | Sell |
|
|||||
|
2020
Q2 | $274K | Sell |
|
|||||
|
2020
Q1 | $207K | Sell |
|
|||||
|
2019
Q4 | $307K | Sell |
|
|||||
|
2019
Q3 | $305K | Sell |
|
|||||
|
2019
Q2 | $356K | Sell |
|
|||||
|
2019
Q1 | $425K | Buy |
|
|||||
|
2018
Q4 | $445K | Buy |
|
|||||
|
2018
Q3 | $398K | Sell |
|
|||||
|
2018
Q2 | $708K | Buy |
|
|||||
|
2018
Q1 | $489K | Sell |
|
|||||
|
2017
Q4 | $412K | Buy |
|
|||||
|
2017
Q3 | $384K | Buy |
|
|||||
|
2017
Q2 | $341K | Buy |
|
|||||
|
2017
Q1 | $267K | Sell |
|
|||||
|
2016
Q4 | $257K | Buy |
|
|||||
|
2016
Q3 | $224K | Buy |
|
|||||
|
2016
Q2 | $251K | Buy |
|